Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

por Shay, Rebecca C., Diamond, Jennifer R., Kagihara, Jodi A., Sams, Sharon B.
Publicado 2020

Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval

por Stoen, Ericson, Kagihara, Jodi, Shagisultanova, Elena, Fisher, Christine M., Nicklawsky, Andrew, Kabos, Peter, Borges, Virginia F., Diamond, Jennifer R.
Publicado 2021

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials

por Schreiber, Anna R., Kagihara, Jodi A., Weiss, Jennifer A., Nicklawsky, Andrew, Gao, Dexiang, Borges, Virginia F., Kabos, Peter, Diamond, Jennifer R.
Publicado 2021

Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study

por Schreiber, Anna R., Kagihara, Jodi, Eguchi, Megan, Kabos, Peter, Fisher, Christine M., Meyer, Elisabeth, Molina, Elizabeth, Kondapalli, Lavanya, Bradley, Cathy J., Diamond, Jennifer R.
Publicado 2021

Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center

por Weiss, Jennifer A., Nicklawsky, Andrew, Kagihara, Jodi A., Gao, Dexiang, Fisher, Christine, Elias, Anthony, Borges, Virginia F., Kabos, Peter, Davis, Sarah L., Leong, Stephen, Eckhardt, Sue Gail, Diamond, Jennifer R.
Publicado 2020